FDA Labeling Rule Creates Liability Risk For Generics Cos.
A new U.S. Food and Drug Administration proposal to let generic-drug manufacturers independently update product labeling when they discover new safety data could open them up to failure-to-warn suits and dilute...To view the full article, register now.
Already a subscriber? Click here to view full article